Strategic Development & Manufacturing Partners

NSI plans to outsource development activities as follows:

   Analytical and Microbiological testing, AAI Pharma, Bilcare and CBL;

   Storage and distribution,  Bilcare;

   Toxicological and pharmacokinetic studies, to be determined;

   John Royer, corporate attorney;

   Lahive and Cockfield, patent attorney.